Abic Vincristine Sulphate Injection
Clinical Summary
Quick overview from the medicine insert
Indication
Vincristine Sulphate is indicated for the treatment of various types of cancer, including acute lymphoblastic leukaemia, lymphoma, and other malignancies.
Dosage (summary)
The typical starting dose for adults is 1.4 mg/m² IV once weekly, not exceeding 2 mg per dose. Dosage may vary based on the specific condition being treated and patient response.
Onset of Action / Duration
Onset of action is typically within 24 hours, with peak effects observed within 1-2 weeks.
Special Populations
- Pediatric patients
- Elderly patients
- Patients with hepatic impairment
- Patients with renal impairment
Pregnancy & Breastfeeding
Vincristine Sulphate is contraindicated during pregnancy and lactation due to potential harm to the fetus and nursing infant.
Key Drug Interactions
- CYP3A4 inhibitors may increase vincristine levels.
- CYP3A4 inducers may decrease vincristine levels.
- Concurrent use with other neurotoxic agents may increase the risk of peripheral neuropathy.
Contraindications
- Hypersensitivity to vincristine or any component of the formulation.
- Patients with demyelinating conditions.
- Patients with severe liver dysfunction.
Common side effects
- Peripheral neuropathy
- Constipation
- Alopecia
- Nausea and vomiting
- Bone marrow suppression
Counselling Points
- Advise patients to report any signs of peripheral neuropathy, such as tingling or numbness.
- Encourage patients to maintain hydration and manage constipation.
- Inform patients about the potential for hair loss and discuss options for coping.
Serious warnings
- Vincristine is a vesicant; extravasation can cause severe tissue damage.
- Monitor for signs of infection due to bone marrow suppression.
- Use caution in patients with a history of seizures or neurotoxicity.
Important Disclaimer
The Abic Vincristine Sulphate Injection professional information leaflet below is the property of Teva Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
